	A novel ensemble-based genetic algorithm for enhanced feature selection in lung and pancreatic cancer diagnosis. Discov Oncol Shabir S, Chishti MA. PMID: 42237052 [PubMed - as supplied by publisher]
	The evolution of non-surgical management in stage III non-small cell lung cancer. BJC Rep Patel MS, Hammond A, Dee EC, Iyengar P. PMID: 42236951 [PubMed]
	The predictive value of systemic inflammation response index and albumin-to-globulin ratio for prognosis in non-small cell lung cancer. Sci Rep Xu Q, Deng Y, Cai Y, Yu S, Kang M, He F. PMID: 42236852 [PubMed - as supplied by publisher]
	A comprehensive analysis and visualization of immune-related adverse events in lung cancer immunotherapy a bibliometric study. Discov Oncol Li X, Zhang F, Xu X. PMID: 42236618 [PubMed - as supplied by publisher]
	Burden of COPD and lung cancer attributable to household air pollution in Morocco: a secondary analysis using population attributable fractions. BMJ Open El Harch I, Mahfoudi H, Benmaamar S, Tachfouti N, El Rhazi K. PMID: 42236099 [PubMed - in process]
	Uncertainty quantification framework for AI-based survival models: Application to lung cancer prognosis in older adults for informed decision-making. Artif Intell Med Lee D, Tran TN, Jeong J, Kwon H, Cho H. PMID: 42235349 [PubMed - as supplied by publisher]
	Development of a clinical prediction model using digital device data for interstitial lung disease in patients with unresectable stage III non-small cell lung cancer treated with durvalumab. Lung Cancer Ikeda S, Kenmotsu H, Koto R, Hirai T, Ogi M, Sato Y, Iwao C, Kitagawa H, Yamamoto N. PMID: 42235163 [PubMed - as supplied by publisher]
	Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators. J Clin Oncol Doroshow DB, Leal TA, Waqar SN, Borghaei H, Camidge DR, Dragnev KH, Edelman MJ, Gandara DR, Gerber DE, Gray JE, Hirsch FR, Husain H, Kozono DE, Leighl NB, Li BT, Mack PC, Neal JW, Paik PK, Patel SP, Riess JW, Redman MW, Reckamp KL. PMID: 42234933 [PubMed - as supplied by publisher]
	Complex versus simple segmentectomy in non-small cell lung cancer: a single-center, retrospective study. Gen Thorac Cardiovasc Surg Seto K, Matsubayashi Y, Noritake O, Matsui T, Suzuki S, Kuroda H, Masago K, Sakakura N. PMID: 42234389 [PubMed - as supplied by publisher]
	Expression levels of microRNA-550a-5p in patients with spinal metastases from non-small cell lung cancer. Per Med Guo H, Li J, Li T, Ruan J. PMID: 42233655 [PubMed - as supplied by publisher]
	Extracellular Vesicles in Exhaled Breath Condensate as Emerging Biomarkers in Lung Cancer. Am J Physiol Cell Physiol Schmidt B, Tambon C, Cortopassi F, Bokemeyer C, Saul MJ. PMID: 42233525 [PubMed - as supplied by publisher]
	Plain language summary: comparing ivonescimab plus chemotherapy with tislelizumab plus chemotherapy in people with advanced squamous non-small cell lung cancer in the HARMONi-6 study. Future Oncol Chen Z, Yang F, Jiang Z, Sun L, Wu L, Han Z, Fan Y, Zhao Y, Li X, Xu H, Meng X, Liu Y, Zhang Z, Luo H, Ma X, Ma X, Shi Q, Zhang Z, Yang R, Wang P, Pan P, Ai X, Li J, Pu X, Wang Z, Fang J, He M, He Y, Guo S, Li J, Wang H, Zhang J, Chu Q, Liu X, Ying S, Wu H, Sun H, Ji Y, Zhou M, Cao C, Tang K, Li Z, Li D, Zhang Z, Li J, Zhou J, Yang H, Du Y, Yang H, Shi J, Chen H, Moore AC, Lu S. PMID: 42233228 [PubMed - as supplied by publisher]
	Tumor immune microenvironment in non-small cell lung cancer progression. Front Immunol Jiang J, Zhong M, Wang J, Zhang Z, Li W, Deng Z. PMID: 42233035 [PubMed - in process]
	Serum metabolomic signatures predict clinical outcomes in advanced non-small cell lung cancer treated with pembrolizumab plus platinum-based chemotherapy. Front Immunol May P, Winter C, Hubrecht I, Patenge A, Strathmeyer S, Geyer R, Heelemann S, Stratmann J, Safi S, Klein H, Schneller F, Bassermann F, Becker von Rose A. PMID: 42233027 [PubMed - in process]
	Perioperative outcomes of robot-assisted versus video-assisted thoracoscopic surgery for non-small cell lung cancer: a meta-analysis focusing on real-world clinical studies in the past 10 years. Front Oncol Zhu J, Meng X, Hu L. PMID: 42232542 [PubMed]
	Techniques of double-sleeve lobectomy for lung cancer: a narrative review of clinical practice. J Vis Surg Nameghi FH, Aresu G, Peryt A, Coonar AS. PMID: 42232282 [PubMed]
	Comment On: "Association Between Admission Prognostic Nutritional Index and Pulmonary Infection Status in Hospitalized Lung Cancer Patients: A Retrospective Cohort Study" [Letter]. J Inflamm Res Dan Q. PMID: 42232157 [PubMed]
	Uniportal video-assisted thoracoscopic surgery segmentectomy for early-stage non-small cell lung cancer: indications and surgical technique. J Vis Surg Suzuki J, Watanabe H, Takamori S, Uchida T, Shiono S. PMID: 42232042 [PubMed]
	Systemic Inflammation Modifies the Efficacy of Bevacizumab Added to Atezolizumab Plus Chemotherapy for Advanced Non-Squamous Non-Small Cell Lung Cancer: A Multicenter Retrospective Study. Thorac Cancer Yamauchi K, Matsumoto K, Shiroyama T, Tamiya A, Tamiya M, Tsukaguchi A, Miyazaki A, Komuta K, Mihashi Y, Machiyama H, Kanaoka K, Kuge T, Kinehara Y, Shoshihara N, Niki T, Kato S, Nishikawa Y, Azuma K, Tanaka S, Osa A, Suzuki H, Nagatomo I, Uchida J, Takeda Y, Kumanogoh A. PMID: 42231603 [PubMed - in process]
	Mechanism study of RUNX1/NSUN2 upregulating fatty acid-binding protein 5 through 5-methylcytosine methylation to mediate lipid metabolic reprogramming to promote immunotherapy resistance in non-small cell lung cancer. Respir Res He C, Li Y, He H, Zhou F, Fu B, Bu J, Wang M, Kong X, Li P, Ni B, Xu S. PMID: 42231351 [PubMed - as supplied by publisher]

Articles 1 - 20 / 159211

Page 1 of 7961



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy